Digital Pharma

Genk ·KBO/BCE: BE 0771.989.346

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	30-07-2025	1 d early	2025-00329298
31-12-2023	31-07-2024	26-07-2024	5 d early	2024-00288731
31-12-2022	31-07-2023	22-07-2023	9 d early	2023-00260051

Metric	This company	Sector median	Position in the sector
Solvency	-5.4%	42.7%	better than 10% of 115 sector peers
Net result	€-152k	€32k	better than 11% of 115 sector peers
Equity	€-48k	€130k	better than 6% of 115 sector peers
Gross operating margin	€132k	€63k	better than 68% of 114 sector peers
Staff costs	€151k	€351k	higher than 38% of 31 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€882k
Fixed assets	21/28	€766k
Intangible fixed assets	21	€749k
Tangible fixed assets	22/27	€16k
Financial fixed assets	28	€250
Current assets	29/58	€117k
Amounts receivable within one year	40/41	€70k
Cash & bank	54/58	€45k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€882k
Equity	10/15	€-48k
Contributions / capital	10/11	€384k
Reserves	13	€841
Accumulated profits (losses)	14	€-433k
Amounts payable	17/49	€930k
Amounts payable after one year	17	€640k
Amounts payable within one year	42/48	€163k
Trade debts payable within one year	44	€65k
Income statement
Gross operating margin	9900	€132k
Operating result	9901	€-142k
Financial income	75	€10
Financial charges	65	€9k
Result before taxes	9903	€-151k
Income taxes	67/77	€348
Net result for the period	9904	€-152k
Result to be appropriated	9905	€-152k

Summary